2009 Form 990-PF - Bill & Melinda Gates Foundation

BILL & MELINDA GATES FOUNDATION 56-2618866
FORM 990PF, PART XV - GRANTS AND CONTRIBUTIONS PAID DURING THE YEAR
RELATIONSHIP TO SUBSTANTIAL CONTRIBUTOR
AND
ATTACHMENT 18 (CONT'D)
RECIPIENT NAME AND ADDRESS FOUNDATION STATUS OF RECIPIENT PURPOSE OF GRANT OR CONTRIBUTION AMOUNT
YALE UNIVERSITY NONE TO PERFORM THE BACKGROUND WORK, PLANNING AND
1,235,296.
PO BOX 208047 509(A)(1)
NEW HAVEN, CT 065208018
DEVELOPMENT OF A PROGRAM GRANT THAT WILL AIM
TO ENHANCE THE USE OF ORAL REHYDRATION
SOLUTION (ORS) IN THE TREATMENT OF ACUTE
DIARRHEA IN YOUNG CHILDREN
YALE UNIVERSITY NONE FOR VIRAL REPLICATION, HIV VIRUSES ARE
100,000.
PO BOX 208047 509(A)(1)
NEW HAVEN, CT 065208018
DEPENDENT UPON PROTEINS, CALLED PROTEASES, TO
APPROPRIATELY CLEAVE PEPTIDES AND FORM
FUNCTIONAL VIRAL PARTICLES. CRAIG CREWS OF
YALE UNIVERSITY IN THE U.S. WILL ATTEMPT TO
EXPLOIT THESE PROTEASES BY DESIGNING A DRUG
WILL CLEAVE ONLY TO HIV PROTEASE AND RELEASE A
CYTOTOXIN THAT RESULTS IN PROGRAMMED CELL
YALE UNIVERSITY NONE DAVID A. SPIEGEL OF YALE UNIVERSITY IN THE U.S.
100,000.
PO BOX 208047 509(A)(1)
NEW HAVEN, CT 065208018
DEATH.
WILL PURSUE AN ANTIBIOTIC STRATEGY CALLED
"BIOSYNTHETIC IMMUNOTARGETING." STREPTOCOCCUS
PNEUMONIAE WILL BE FED SMALL MOLECULES WHICH THEY
WILL INCORPORATE INTO THEIR CELL WALLS. THESE
SMALL MOLECULES CONTAIN AN EPITOPE RECOGNIZED BY
ANTIBODIES IN THE HUMAN BLOODSTREAM, LEADING TO
IMMUNE CLEARANCE INDEPENDENT OF BACTERIAL
ANTIGENS, REPRESENTING A UNIQUE, RESISTANCE-FREE
APPROACH TO PNEUMOCOCCAL DISEASE.
YEAR UP INC NONE TO SUPPORT YOUNG ADULT SUCCESS AND IMPROVE
209,079.
93 SUMMER ST 509(A)(1)
5TH FLOOR
BOSTON, MA 02110
FOR PUBLIC DISCLOSURE
327 OF 519
POST SECONDARY OUTCOMES FOR LOW INCOME YOUNG
ADULTS
ATTACHMENT 18